Video

Q&A With Robert Eckel From the University of Colorado: Major Medical Organizations Largely Agree on New Cholesterol Guidelines

Author(s):

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

Robert Eckel, MD, from the University of Colorado Anschutz Medical Campus discussed new guidelines that have been adopted by the American Heart Association, the American College of Cardiology, and the American Diabetes Assocation during the latter's 75th Annual Scientific Sessions in Boston. While there are only some minor disagreements, Eckel said one major difference is whether a risk management program could help patients monitor their health.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.